Natco Pharma Ltd.

Merrill Lynch Capital Market Espana SA SV has sold 199,668 shares of Natco Pharma in an open market transaction. The shares were sold at Rs 589.55 each on National Stock Exchange (NSE) on July 29, 2013.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.